Get started
Author

Kelly N. Casteel

Observed names: Kelly Casteel, Kelly N Casteel
ORCID: 0000-0001-8179-0953
Observed ORCID: 0000-0001-8179-0953
OpenAlex ID: A5074364496
Apixaban vs Enoxaparin for Post-Surgical Extended-Duration Venous Thromboembolic Event Prophylaxis: A Prospective Quality Improvement Study
2022 · Mary E. Westerman, Kelly K. Bree, et al. · The Journal of Urology · 28
Elevated Ferritin Predicts for Inferior Survival in Patients with Acute Leukemia and May be an Early Marker of a Underlying Systemic Pathologic Inflammation
2016 · Preetesh Jain, Kelly Casteel, et al. · Blood · 5
Paraneoplastic Eosinophilia (PNE): A Rare Finding in a Patient With Metastatic Medullary Thyroid Carcinoma
2021 · Mark Anthony Jara, Kelly N Casteel, et al. · Journal of the Endocrine Society · 1
Platelet-refractoriness and the clinical impact in leukemia population at a metropolitan academic cancer center
2019 · Wei Yang, Ashok Tholpady, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1
Benign Hematological Diseases in Cancer Patients
2026 · Hugo R. Lara-Martinez, Kelly Meza-Capcha, et al. · Springer eBooks
Reducing the wastage of fresh frozen plasma in a hospital blood bank through the use of Six Sigma principles.
2022 · Robert Harrison Hester, Estella Castillo, et al. · Journal of Clinical Oncology
Mp16-14 Apixaban Versus Enoxaparin for Post-surgical Extended Duration Vte Prophylaxis: a Prospective Quality Improvement Study
2022 · Mary Westerman, Kelly Bree, et al. · The Journal of Urology
Benign Hematological Diseases in Cancer Patients
2019 · Kelly N. Casteel, Michael H. Kroll · Springer eBooks
Benign Hematological Diseases in Cancer Patients
2019 · Kelly N. Casteel, Michael H. Kroll · Springer eBooks
Works count: 9
Citation count: 35
H-index: 2
I10-index: 1
Year
Topic
Type